Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects
- PMID: 26884760
- PMCID: PMC4738975
- DOI: 10.1155/2016/6739150
Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects
Abstract
Aim of the study was to examine cardiorespiratory parameters at individual ventilatory threshold (IVT) and peak exercise capacity ([Formula: see text]) in outpatient diabetic and sarcopenic obese subjects. Seventeen obese subjects (BMI: 36.6 ± 4.1 kg·m(-1)) and sixteen SO subjects (BMI: 37.0 ± 7.3 kg·m(-1)) were compared with sixteen T2DM subjects (BMI: 37.7 ± 5.6 kg·m(-1)). All groups performed an incremental exercise test on a treadmill according to their physical ability. [Formula: see text], %HRmax, and maximal metabolic equivalent (METmax) were evaluated at maximal effort. Moreover, [Formula: see text], %[Formula: see text], %HRmax, %HRR, ΔHR, and METivt were assessed at IVT. No significant differences were found in any physiological parameters at maximal effort ([Formula: see text], %HRmax, and METmax) in all groups. On the contrary, [Formula: see text], %[Formula: see text], %HRmax, %HRR, ΔHR, and METivt were significantly lower in T2DM subjects as compared to OB and SO subjects at IVT (p < 0.05). Our results show that while at maximal effort there are no differences among groups, at IVT the physiological parameters are lower in T2DM subjects than in OB and SO subjects. Therefore, due to the differences observed in the groups, we suggest usng the IVT as a useful parameter to prescribe aerobic exercise in obese with sarcopenia or diabetes mellitus conditions.
Comment in
-
Comment on "Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects".Int J Endocrinol. 2017;2017:1754215. doi: 10.1155/2017/1754215. Epub 2017 Nov 16. Int J Endocrinol. 2017. PMID: 29348748 Free PMC article. No abstract available.
-
Comment #2 on "Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects".Int J Endocrinol. 2018 Nov 28;2018:4026463. doi: 10.1155/2018/4026463. eCollection 2018. Int J Endocrinol. 2018. PMID: 30622565 Free PMC article. No abstract available.
References
-
- WHO. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: Word Health Organization; 2014. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_re....
-
- Waxman A. Why a global strategy on diet, physical activity and health? World review of nutrition and dietetics. 2005;95:162–166. - PubMed
-
- Evans W. J., Campbell W. W. Sarcopenia and age-related changes in body composition and functional capacity. Journal of Nutrition. 1993;123(2):465–468. - PubMed
-
- Donini L. M., Poggiogalle E., Migliaccio S., Pinto A., Lubrano C., Lenzi A. Sarcopenic obesity: correlation with clinical, functional, and psychological status in a rehabilitation setting. Food and Nutrition Sciences. 2014;5(20):2020–2031. doi: 10.4236/fns.2014.520213. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
